FAKTOR OPTIONSSCHEIN - MERCK & CO. | Real-time BOERSE MUENCHEN 08:25:45 2024-07-01 EDT | ||
| 19.33 EUR | +5.48% |
|
| Current month | -5.78% | ||
| 1 month | -4.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 19.33 | +5.48% |
| 24-06-28 | 18.33 | -2.18% |
| 24-06-27 | 18.73 | +7.58% |
| 24-06-26 | 17.41 | +1.71% |
| 24-06-25 | 17.12 | -0.98% |
Real-time BOERSE MUENCHEN
Last update July 01, 2024 at 08:25 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG2ZGA |
| ISIN | DE000GG2ZGA5 |
| Date issued | 2024-01-31 |
| Strike | 185.7 $ |
| Maturity | Unlimited |
| Parity | 2.94 : 1 |
| Emission price | 21.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.89 € |
|---|---|
| Lowest since issue | 16.95 € |
| Spread | 0.1 € |
| Spread % | 0.52% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- Certificat
